203 filings
Page 2 of 11
8-K
82hbmkx n2kc
14 Aug 23
Evofem Biosciences Announces Financial Results for the Second Quarter of 2023
5:25pm
8-K
esf67ejjaq a87db7xa
10 Aug 23
Entry into a Material Definitive Agreement
5:29pm
8-K
bkzz88r49v8j9
17 Jul 23
Material Modifications to Rights of Security Holders
4:05pm
8-K
s4nc5eh llfm
10 Jul 23
Entry into a Material Definitive Agreement
5:16pm
8-K
sx4d92lxex5
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
q0w7adjv8 vtw03avagq
16 Jun 23
Evofem Biosciences Announces Financial Results for the First Quarter of 2023
4:01pm
8-K
qndznvgd
1 Jun 23
Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023
8:36am
8-K
9xl1ke4qrz0v4 ol7
17 May 23
Evofem Biosciences Announces 1-for-125 Reverse Stock Split
5:13pm
8-K
vmhsv4xm5blaa8
5 May 23
Other Events
5:00pm
8-K
keol2fkx 6r
28 Apr 23
Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update
6:50am
8-K
39fh2o
14 Apr 23
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary
9:05am
8-K/A
istxao320f3
11 Apr 23
Entry into a Material Definitive Agreement
8:17pm
8-K
ejx7rngnliz xm5nf
10 Apr 23
Entry into a Material Definitive Agreement
5:26pm
8-K
3vda8oh j6
24 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
8hkgpqhwvwkj3hwfl7nh
20 Mar 23
Evofem Biosciences Announces Cost Reduction Measures
9:55pm
8-K
69wvkwbvvpate684
16 Mar 23
Submission of Matters to a Vote of Security Holders
7:07pm
8-K
gmrrazjmjib2gort85z
14 Mar 23
Entry into a Material Definitive Agreement
9:00am
8-K
6txsgj 145ff14og60s
10 Mar 23
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:27pm
8-K
owge83q5mi8zfkgvu
9 Mar 23
Evofem Biosciences Appoints Interim Chief Financial Officer
4:01pm
8-K
cbphtws7ct4r42vck
23 Feb 23
Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value
8:59pm